WHO monographs on selected medicinal plants - travolekar.ru

WHO monographs on selected medicinal plants - travolekar.ru WHO monographs on selected medicinal plants - travolekar.ru

20.01.2015 Views

ong>WHOong> ong>monographsong> on selected medicinal plants cin-induced gastric ulceration was reduced in animals treated with 400 mg/ kg bw of the methanol extract (26). Intragastric administration of an ethanol extract of the crude drug at a dose of 5.0 or 15.0 g/kg bw inhibited hydrochloric acid-induced gastric ulceration in mice (27). Anti-inflammatory activity Magnolol, isolated and purified from the crude drug, inhibited mouse hind-paw oedema induced by carrageenan, compound 48/80 and polymyxin B and reversed passive Arthus reaction when administered orally at a dose of 30 mg/kg bw (28). Antioxidant activity The accumulation of oxygen-free radicals and activation of neutrophils are implicated in the pathophysiological mechanisms that mediate myocardial ischaemia/reperfusion injury. Thus, antioxidants are purported to have cardioprotective activity. The antioxidant effect of magnolol was evaluated in an open-chest anaesthetized rat model of myocardial ischaemia/reperfusion injury (29). Intravenous pretreatment with magnolol, at a dose of 0.2 and 0.5 μg/kg bw at 10 minutes prior to 45 minutes of left coronary artery occlusion, reduced the incidence and duration of ventricular fibrillation and reduced mortality when compared with the control group. After 1 hour of reperfusion, pretreatment with magnolol reduced infarct size. In addition, magnolol, at a dose of 0.2 μg/kg bw, reduced superoxide anion production and myeloperoxidase activity, an index of neutrophil infiltration in the ischaemic myocardium (29). Restenosis, a common complication after balloon angioplasty, involves a number of cytokines, chemotactic factors and growth factors. Antioxidants have been shown to inhibit intimal thickening after balloon injury in hyperlipidaemic animals. The effects of magnolol on the expression of monocyte chemotactic protein-1 and on intimal response in balloon-injured aorta of cholesterol-fed rabbits were investigated. The animals were fed a 2% highcholesterol diet together with daily intramuscular injection of either 1 μg/kg bw of magnolol or vehicle solvent for a total of 6 weeks, while 10 rabbits fed a regular diet served as a control group. A balloon denudation of abdominal aorta was performed in each group at the end of the third week, and aortas were harvested at the end of 6 weeks. Treatment with magnolol significantly inhibited copper-induced low-density lipoprotein oxidation in cholesterolfed rabbits and reduced atheroma formation (p < 0.05) in thoracic aortas without lowering serum cholesterol. The intimal response was significantly attenuated in magnolol-treated rabbits receiving high cholesterol when compared to those of the control high-cholesterol group (p < 0.05) (30). 172

Cortex Magnoliae The protective effect of magnolol against hypoxia-induced cell injury in cortical neuron-astrocyte mixed cultures was assessed after exposure of the cells to chemical hypoxia (0.5 mm potassium cyanide). Treatment with magnolol (10 and 100 μM) significantly reduced potassium cyanideinduced lactose dehydrogenase release in a concentration-dependent manner (30). The effects of magnolol on the course of sepsis, survival rate and biochemical parameters were analysed in rats with induced sepsis. Intragastric administration of magnolol, at doses ranging from 10 -9 g/kg to 10 -5 g/ kg bw, administered either before or after induction of sepsis by cecal ligation and puncture did not alter the course of sepsis induced by two cecal punctures. However, when one cecal puncture was performed, a moderately evolving type of sepsis was induced, and the survival rate of affected rats was significantly improved by pretreatment with 10 -7 g/kg magnolol (p < 0.05). The intensity of lipid peroxidation in plasma, liver and lung of septic rats was also attenuated in a treatment-dependent manner (31). Anxiolytic activity In rat brain membranes, honokiol and magnolol at a concentration of 5.0 μM, enhanced binding of [3H]muscimol and [3H]flunitrazepam to the -aminobutyric acid receptor, but honokiol was 2.5 to 5.2 times more potent than magnolol. Honokiol and magnolol also enhanced the potentiating effect of 200 nM -aminobutyric acid on [3H]flunitrazepam binding with EC 50 values of 0.61 μM and 1.6 μM. Honokiol and magnolol increased [3H]muscimol binding by approximately 68% with EC 50 values of 2.3 and 12.0 μM, respectively (32). In elevated plus-maze tests, treatment of mice with honokiol prolonged the time spent in the open arms, showing an anxiolytic effect. Seven daily treatments with 0.1–1 mg/kg bw honokiol, demonstrated an anxiolytic effect with the optimal dose at 0.2 mg/kg bw. These results suggest that honokiol is the chemical responsible for the anxiolytic effect of the water extract of the bark in vivo (33). Cardiovascular effects The effect of magnolol on coronary circulation and vascular resistance was assessed in anaesthetized rabbits using a Doppler velocimetry probe. Thirty-nine rabbits received intravenous injection of either vehicle (n = 5), magnolol (10 -6 –10 -4 g/kg bw) or nitroglycerin. Magnolol did not change blood pressure or coronary blood flow velocity, but at a dose of 10 -4 g/kg, decreased coronary vascular resistance significantly more than vehicle (p < 0.001). Nitroglycerin increased coronary blood flow velocity and 173

Cortex Magnoliae<br />

The protective effect of magnolol against hypoxia-induced cell injury<br />

in cortical neur<strong>on</strong>-astrocyte mixed cultures was assessed after exposure of<br />

the cells to chemical hypoxia (0.5 mm potassium cyanide). Treatment with<br />

magnolol (10 and 100 μM) significantly reduced potassium cyanideinduced<br />

lactose dehydrogenase release in a c<strong>on</strong>centrati<strong>on</strong>-dependent<br />

manner (30).<br />

The effects of magnolol <strong>on</strong> the course of sepsis, survival rate and biochemical<br />

parameters were analysed in rats with induced sepsis. Intragastric<br />

administrati<strong>on</strong> of magnolol, at doses ranging from 10 -9 g/kg to 10 -5 g/<br />

kg bw, administered either before or after inducti<strong>on</strong> of sepsis by cecal ligati<strong>on</strong><br />

and puncture did not alter the course of sepsis induced by two cecal<br />

punctures. However, when <strong>on</strong>e cecal puncture was performed, a moderately<br />

evolving type of sepsis was induced, and the survival rate of<br />

affected rats was significantly improved by pretreatment with 10 -7 g/kg<br />

magnolol (p < 0.05). The intensity of lipid peroxidati<strong>on</strong> in plasma, liver<br />

and lung of septic rats was also attenuated in a treatment-dependent<br />

manner (31).<br />

Anxiolytic activity<br />

In rat brain membranes, h<strong>on</strong>okiol and magnolol at a c<strong>on</strong>centrati<strong>on</strong> of<br />

5.0 μM, enhanced binding of [3H]muscimol and [3H]flunitrazepam to<br />

the -aminobutyric acid receptor, but h<strong>on</strong>okiol was 2.5 to 5.2 times more<br />

potent than magnolol. H<strong>on</strong>okiol and magnolol also enhanced the potentiating<br />

effect of 200 nM -aminobutyric acid <strong>on</strong> [3H]flunitrazepam binding<br />

with EC 50<br />

values of 0.61 μM and 1.6 μM. H<strong>on</strong>okiol and magnolol increased<br />

[3H]muscimol binding by approximately 68% with EC 50<br />

values<br />

of 2.3 and 12.0 μM, respectively (32).<br />

In elevated plus-maze tests, treatment of mice with h<strong>on</strong>okiol prol<strong>on</strong>ged<br />

the time spent in the open arms, showing an anxiolytic effect. Seven<br />

daily treatments with 0.1–1 mg/kg bw h<strong>on</strong>okiol, dem<strong>on</strong>strated an<br />

anxiolytic effect with the optimal dose at 0.2 mg/kg bw. These results<br />

suggest that h<strong>on</strong>okiol is the chemical resp<strong>on</strong>sible for the anxiolytic effect<br />

of the water extract of the bark in vivo (33).<br />

Cardiovascular effects<br />

The effect of magnolol <strong>on</strong> cor<strong>on</strong>ary circulati<strong>on</strong> and vascular resistance<br />

was assessed in anaesthetized rabbits using a Doppler velocimetry probe.<br />

Thirty-nine rabbits received intravenous injecti<strong>on</strong> of either vehicle (n =<br />

5), magnolol (10 -6 –10 -4 g/kg bw) or nitroglycerin. Magnolol did not change<br />

blood pressure or cor<strong>on</strong>ary blood flow velocity, but at a dose of 10 -4 g/kg,<br />

decreased cor<strong>on</strong>ary vascular resistance significantly more than vehicle<br />

(p < 0.001). Nitroglycerin increased cor<strong>on</strong>ary blood flow velocity and<br />

173

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!